Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C

Patients with chronic hepatitis C virus (HCV) develop hepatocellular carcinoma (HCC) regardless of achieving a sustained viral response (SVR). Because advanced liver fibrosis is a powerful risk factor for HCC, we analyzed the association between autotaxin (ATX), a liver fibrosis marker, and post-SVR...

Descripción completa

Detalles Bibliográficos
Autores principales: Takemura, Kazuya, Takizawa, Etsuko, Tamori, Akihiro, Nakamae, Mika, Kubota, Hiroshi, Uchida-Kobayashi, Sawako, Enomoto, Masaru, Kawada, Norifumi, Hino, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350226/
https://www.ncbi.nlm.nih.gov/pubmed/32630450
http://dx.doi.org/10.3390/ijms21124517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350226/
https://www.ncbi.nlm.nih.gov/pubmed/32630450
http://dx.doi.org/10.3390/ijms21124517

Ejemplares similares